News 2024-12-06
Porton Recognized as an Exemplary Case for Sustainable Development
Porton was recently selected as a "2024 Exemplary
Case for Sustainable Development Among Chinese Listed Companies" by the
China Association of Public Companies, in recognition of its Environmental,
Social, and Governance (ESG) management practices once again.
Porton has disclosed its first Social
Responsibility Report since 2017 and its inaugural ESG report in 2024,
demonstrating continuous improvement in its management and performance in
sustainable development. By adhering to the four core ESG concepts—Green
Development, Promoting Common Progress, building a Healthy Society, and
Enhancing Corporate Governance—Porton is dedicated to integrating ESG into its
corporate strategy and operations, aiming for high-quality development.
On one hand, we drive ESG initiatives from top
to bottom, having established a comprehensive governance structure that
encompasses governance, management, and execution, thus providing institutional
support for implementing our ESG efforts. On the other hand, we foster
management measures and performance enhancements from bottom to top by creating
actionable work plans with ongoing follow-up, identifying gaps for improvement,
and conducting ESG training to elevate awareness among our employees.
Concerning
the management system, we have developed and updated policies such as the
"Diversity, Equity, and Inclusion Policy," "Personal Information
Protection Policy," and "Trade Secret Protection Management
System" to better manage and oversee related issues. Additionally, our
public welfare program, “WeCare,” remains focused on rare diseases such as
Duchenne muscular dystrophy (DMD). We supported families of DMD patients in
attending the "13th China Rare Disease Summit Forum" and organized charity
bazaars and charity runs.
This year,
we conducted multiple ESG training sessions, including those on trade secret
protection, anti-fraud measures, water resource management, and ESG management
enhancement, to further raise employee awareness.
Others
More
News 2025-03-07
DCAT Week 2025 — The Premier Event Connecting Biotech and Pharmaceutical Industries
DCAT Week is the premier annual event for the biotechnology and pharmaceutical manufacturing value chain. With senior decision-makers in attendance, it provides a unique platform for healthcare companies of all sizes to conduct high-level business meetings and foster strategic partnerships.

News 2025-03-07
Porton Wins Outsourced Pharma 2025 CDMO Leadership Award
In March 2025, Porton Pharma Solutions Ltd. was honored with the "Global Small Molecule API Award" at the 14th Outsourced Pharma CDMO Leadership Awards, recognizing its exceptional end-to-end services across the global small molecule drug lifecycle. This award reaffirms Porton's outstanding performance in the CDMO sector for pharmaceutical R&D and manufacturing worldwide.